Everyone knows that faster and cheaper genome sequencing is ushering in a new era of healthcare. What many people don’t fully realize, however, is how the confluence of “big biology” with “big data” is opening huge opportunities for innovative tech startups and established players alike—in areas from next-generation sequencing to data acquisition, storage, distribution, analysis, and more.
With its expertise in high-performance computing, predictive analytics, and software development, coupled with its leadership in genomics, brain science, biotechnology, and digital health, San Diego is uniquely poised to be a leader in this data-biology confluence.
Please join Xconomy San Diego for a half-day forum that will highlight the prospects—and challenges—facing technology innovators on both the big data and big biology sides of this equation.
Ilkay Altintas, Chief Data Science Officer, San Diego Supercomputer Center
John Blume, CSO, Applied Proteomics
Francis deSouza, President and successor CEO, Illumina
Doug Eveland, CIO, CureMetrix
Lucian Iancovici, Senior Investment Manager, Qualcomm Life Fund
Kim Kamdar, Partner, Domain Associates
Stephen Kingsmore, President and CEO, Rady Pediatric Genomics and Systems Medicine Institute
Rob Knight, Professor of Pediatrics and Computer Science & Engineering, UC San Diego
Lance Myers, CTO, Sentrian
Franz Och, Chief Data Scientist, Human Longevity
Aditya Rajagopal, CTO, ChromaCode
Naveen Rao, Founder and CEO, Nervana Systems
Nicholas Schork, Professor and Director of Human Biology, J. Craig Venter Institute
Pieter van Rooyen, President and CEO, Edico Genome
Registration: 1:00 – 2:00 pm
Program: 2:00 – 5:45 pm
Networking reception: 5:45 – 6:45 pm
Regular Registration: $175
Startup Special: $95
At the Door: $195
This event is sold out. Please visit our registration page to add your name to the waitlist, and we will contact you if a ticket becomes available.